Molecular targeting in colorectal cancer and the role of KRAS mutation testing in the management of metastatic colorectal cancer

被引：0
|
作者：
McIntire, Maria G. [1 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2010年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
172
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [31] KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
    Radanova, Maria
    Mihaylova, Galya
    St Stoyanov, George
    Draganova, Vyara
    Zlatarov, Aleksandar
    Kolev, Nikola
    Dimitrova, Eleonora
    Conev, Nikolay
    Ivanova, Diana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [32] GENETIC ANALYSIS OF KRAS MUTATION STATUS IN METASTATIC COLORECTAL CANCER PATIENTS
    Zavodna, K.
    Konecny, M.
    Spanik, S.
    Galbavy, S.
    Vizvaryova, M.
    Weismanova, E.
    Kausitz, J.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4015 - 4016
  • [33] Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients
    Zavodna, K.
    Konecny, M.
    Krivulcik, T.
    Spanik, S.
    Behulova, R.
    Vizvaryova, M.
    Weismanova, E.
    Galbavy, S.
    Kausitz, J.
    NEOPLASMA, 2009, 56 (03) : 275 - 278
  • [34] Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
    Ucar, Gokhan
    Ergun, Yakup
    Esen, Selin Akturk
    Acikgoz, Yusuf
    Dirikoc, Merve
    Esen, Irfan
    Bal, Oznur
    Uncu, Dogan
    MEDICINE, 2020, 99 (39) : E22407
  • [35] Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients
    Vincenzi, B.
    Cremolini, C.
    Sartore-Bianchi, A.
    Russo, A.
    Mannavola, F.
    Perrone, G.
    Pantano, F.
    Loupakis, F.
    Rossini, D.
    Ongaro, E.
    Bonazzina, E.
    Zoccoli, A.
    De Maglio, G.
    Fontanini, G.
    Falcone, A.
    Santini, D.
    Onetti-Muda, A.
    Siena, S.
    Tonini, G.
    Aprile, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 38 - 38
  • [36] KRAS mutation is highly predictive of cetuximab resistance in metastatic colorectal cancer
    Di Fiore, F.
    Le Pessot, F.
    Lamy, A.
    Charbonnier, F.
    Sabourin, J.
    Paillot, B.
    Frebourg, T.
    Michel, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
    Porru, Manuela
    Pompili, Luca
    Caruso, Carla
    Biroccio, Annamaria
    Leonetti, Carlo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [38] Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
    Manuela Porru
    Luca Pompili
    Carla Caruso
    Annamaria Biroccio
    Carlo Leonetti
    Journal of Experimental & Clinical Cancer Research, 37
  • [39] The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis
    Emilescu, Radu Andrei
    Jinga, Mariana
    Cotan, Horia Teodor
    Popa, Ana Maria
    Orlov-Slavu, Cristina Maria
    Olaru, Mihaela Cristina
    Iaciu, Cristian Ion
    Parosanu, Andreea Ioana
    Moscalu, Mihaela
    Nitipir, Cornelia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [40] Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer
    Ntavatzikos, Anastasios
    Spathis, Aris
    Patapis, Paul
    Machairas, Nikolaos
    Peros, George
    Konstantoudakis, Stefanos
    Leventakou, Danai
    Panayiotides, Ioannis G.
    Karakitsos, Petros
    Koumarianou, Anna
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (32) : 5913 - 5924
12345